News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
BYBEE CLINTON
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
09/15/2022 |
4
| ARCH Venture Fund VIII, L.P. (10% Owner) has filed a Form 4 on Codiak BioSciences, Inc.
Txns:
| Bought 5,000,000 shares
@ $1.5, valued at
$7.5M
Bought 5,000,000 warrants
@ $1.875, valued at
$9.4M
|
|
09/07/2022 |
4
| ARCH Venture Partners IX, LLC (10% Owner) has filed a Form 4 on Vir Biotechnology, Inc.
Txns:
| Disposed of 196,003 shares
@ $0 Disposed of 253,997 shares
@ $0 Acquired 11,763 shares
@ $0 Acquired 1,338 shares
@ $0 Acquired 2,662 shares
@ $0 Disposed of 239,559 shares
@ $0 Disposed of 310,441 shares
@ $0 Acquired 14,383 shares
@ $0 Acquired 1,624 shares
@ $0 Acquired 3,248 shares
@ $0 |
|
09/01/2022 |
4
| ARCH Venture Partners IX, LLC (10% Owner) has filed a Form 4 on Vir Biotechnology, Inc.
Txns:
| Disposed of 217,781 shares
@ $0 Disposed of 282,219 shares
@ $0 Acquired 13,076 shares
@ $0 Acquired 1,475 shares
@ $0 Acquired 2,952 shares
@ $0 Disposed of 217,781 shares
@ $0 Disposed of 282,219 shares
@ $0 Acquired 13,076 shares
@ $0 Acquired 1,475 shares
@ $0 Acquired 2,952 shares
@ $0 |
|
08/26/2022 |
4
| ARCH Venture Partners IX, LLC (10% Owner) has filed a Form 4 on Vir Biotechnology, Inc.
Txns:
| Disposed of 217,781 shares
@ $0 Disposed of 282,219 shares
@ $0 Acquired 13,076 shares
@ $0 Acquired 1,475 shares
@ $0 Acquired 2,952 shares
@ $0 Disposed of 217,781 shares
@ $0 Disposed of 282,219 shares
@ $0 Acquired 13,076 shares
@ $0 Acquired 1,475 shares
@ $0 Acquired 2,952 shares
@ $0 |
|
08/22/2022 |
4
| ARCH Venture Partners IX, LLC (10% Owner) has filed a Form 4 on Vir Biotechnology, Inc.
Txns:
| Disposed of 217,781 shares
@ $0 Disposed of 282,219 shares
@ $0 Acquired 13,076 shares
@ $0 Acquired 1,475 shares
@ $0 Acquired 2,952 shares
@ $0 |
|
08/16/2022 |
4
| ARCH Venture Partners IX, LLC (10% Owner) has filed a Form 4 on Vir Biotechnology, Inc.
Txns:
| Disposed of 217,781 shares
@ $0 Disposed of 282,219 shares
@ $0 Acquired 13,076 shares
@ $0 Acquired 1,475 shares
@ $0 Acquired 2,952 shares
@ $0 Disposed of 217,781 shares
@ $0 Disposed of 282,219 shares
@ $0 Acquired 13,076 shares
@ $0 Acquired 1,475 shares
@ $0 Acquired 2,952 shares
@ $0 Disposed of 217,781 shares
@ $0 |
|
06/10/2022 |
4
| ARCH Venture Partners IX, LLC (10% Owner) has filed a Form 4 on Vir Biotechnology, Inc.
Txns:
| Disposed of 217,781 shares
@ $0 Disposed of 282,219 shares
@ $0 Acquired 13,076 shares
@ $0 Acquired 1,475 shares
@ $0 Acquired 2,952 shares
@ $0 |
|
06/06/2022 |
4
| ARCH Venture Partners IX, LLC (10% Owner) has filed a Form 4 on Vir Biotechnology, Inc.
Txns:
| Disposed of 217,781 shares
@ $0 Disposed of 282,219 shares
@ $0 Acquired 13,076 shares
@ $0 Acquired 4,426 shares
@ $0 |
|
12/22/2021 |
4
| ARCH Venture Partners IX, LLC (10% Owner) has filed a Form 4 on Vir Biotechnology, Inc.
Txns:
| Disposed of 762,233 shares
@ $0 Disposed of 987,767 shares
@ $0 Acquired 45,703 shares
@ $0 Acquired 15,504 shares
@ $0 |
|
12/01/2021 |
4
| ARCH Venture Partners IX, LLC (10% Owner) has filed a Form 4 on Vir Biotechnology, Inc.
Txns:
| Disposed of 217,781 shares
@ $0 Disposed of 282,219 shares
@ $0 Acquired 13,057 shares
@ $0 Acquired 4,428 shares
@ $0 |
|
11/24/2021 |
4
| ARCH Venture Partners IX, LLC (10% Owner) has filed a Form 4 on Vir Biotechnology, Inc.
Txns:
| Disposed of 217,781 shares
@ $0 Disposed of 282,219 shares
@ $0 Acquired 13,057 shares
@ $0 Acquired 4,428 shares
@ $0 |
|
07/06/2021 |
4
| ARCH Venture Partners IX, LLC (10% Owner) has filed a Form 4 on Vir Biotechnology, Inc.
Txns:
| Disposed of 1,742,248 shares
@ $0 Disposed of 2,257,752 shares
@ $0 Acquired 25,279 shares
@ $0 Acquired 8,133 shares
@ $0 |
|
07/02/2021 |
4
| ARCH Venture Partners IX, LLC (10% Owner) has filed a Form 4 on Beam Therapeutics Inc.
Txns:
| Disposed of 200,000 shares
@ $0 Disposed of 200,000 shares
@ $0 Acquired 2,555 shares
@ $0 Acquired 811 shares
@ $0 Acquired 4,686 shares
@ $0 |
|
06/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/24/2021 |
4
| ARCH Venture Partners IX, LLC (10% Owner) has filed a Form 4 on Vir Biotechnology, Inc.
Txns:
| Disposed of 435,562 shares
@ $0 Disposed of 564,438 shares
@ $0 Acquired 6,320 shares
@ $0 Acquired 2,028 shares
@ $0 |
|
06/23/2021 |
4
| ARCH Venture Partners IX, LLC (10% Owner) has filed a Form 4 on Lyell Immunopharma, Inc.
Txns:
| Converted 18,206,358 shares
@ $0 Converted 17,771,216 convertible preferred
@ $0 Converted 435,142 convertible preferred
@ $0 |
|
04/15/2021 |
4
| ARCH Venture Partners IX, LLC (10% Owner) has filed a Form 4 on Karuna Therapeutics, Inc.
Txns:
| Disposed of 75,000 shares
@ $0 Disposed of 75,000 shares
@ $0 Acquired 958 shares
@ $0 Acquired 306 shares
@ $0 |
|
04/09/2021 |
4
| ARCH Venture Partners IX, LLC (10% Owner) has filed a Form 4 on Vir Biotechnology, Inc.
Txns:
| Disposed of 217,781 shares
@ $0 Disposed of 282,219 shares
@ $0 Acquired 3,161 shares
@ $0 Acquired 1,019 shares
@ $0 Disposed of 217,781 shares
@ $0 Disposed of 282,219 shares
@ $0 Acquired 3,161 shares
@ $0 Acquired 1,019 shares
@ $0 |
|
04/02/2021 |
4
| ARCH Venture Partners IX, LLC (10% Owner) has filed a Form 4 on Beam Therapeutics Inc.
Txns:
| Disposed of 200,000 shares
@ $0 Disposed of 200,000 shares
@ $0 Acquired 2,555 shares
@ $0 Acquired 811 shares
@ $0 |
|
04/01/2021 |
4
| ARCH Venture Partners IX, LLC (10% Owner) has filed a Form 4 on Vir Biotechnology, Inc.
Txns:
| Disposed of 217,781 shares
@ $0 Disposed of 282,219 shares
@ $0 Acquired 3,160 shares
@ $0 Acquired 1,014 shares
@ $0 Disposed of 217,781 shares
@ $0 Disposed of 282,219 shares
@ $0 Acquired 3,160 shares
@ $0 Acquired 1,016 shares
@ $0 |
|
03/22/2021 |
4
| ARCH Venture Partners IX, LLC (10% Owner) has filed a Form 4 on Beam Therapeutics Inc.
Txns:
| Disposed of 200,000 shares
@ $0 Disposed of 200,000 shares
@ $0 Acquired 2,553 shares
@ $0 Acquired 810 shares
@ $0 Disposed of 200,000 shares
@ $0 Disposed of 200,000 shares
@ $0 Acquired 2,555 shares
@ $0 Acquired 813 shares
@ $0 |
|
02/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/12/2021 |
4
| ARCH Venture Partners IX, LLC (10% Owner) has filed a Form 4 on Karuna Therapeutics, Inc.
Txns:
| Disposed of 75,000 shares
@ $0 Disposed of 75,000 shares
@ $0 Acquired 958 shares
@ $0 Acquired 306 shares
@ $0 |
|
12/22/2020 |
4
| ARCH Venture Fund VII, L.P. (10% Owner) has filed a Form 4 on 908 Devices Inc.
Txns:
| Converted 5,425,045 shares
@ $0 Bought 300,000 shares
@ $20, valued at
$6M
Converted 2,927,386 preferred shares
@ $0 Converted 981,443 preferred shares
@ $0 Converted 669,977 preferred shares
@ $0 Converted 665,661 preferred shares
@ $0 Converted 180,578 preferred shares
@ $0 |
|
11/24/2020 |
4
| ARCH VENTURE FUND VI LP (10% Owner) has filed a Form 4 on Quanterix Corp
Txns:
| Disposed of 229,006 shares
@ $0 Disposed of 145,994 shares
@ $0 Acquired 854 shares
@ $0 Acquired 853 shares
@ $0 Disposed of 277,514 shares
@ $0 Disposed of 176,920 shares
@ $0 Acquired 1,034 shares
@ $0 Acquired 1,036 shares
@ $0 |
|
11/16/2020 |
4
| ARCH Venture Partners IX, LLC (10% Owner) has filed a Form 4 on Karuna Therapeutics, Inc.
Txns:
| Disposed of 75,000 shares
@ $0 Disposed of 75,000 shares
@ $0 Acquired 958 shares
@ $0 Acquired 306 shares
@ $0 |
|
10/23/2020 |
4
| BYBEE CLINTON (Director) has filed a Form 4 on IMPINJ INC
Txns:
| Exercised 3,411 restricted stock units
@ $0 |
|
10/20/2020 |
4
| ARCH Venture Fund VIII, L.P. (10% Owner) has filed a Form 4 on Codiak BioSciences, Inc.
Txns:
| Converted 1,784,572 shares
@ $0 Converted 831,521 shares
@ $0 Converted 420,368 shares
@ $0 Converted 326,953 shares
@ $0 Converted 191,721 shares
@ $0 Bought 235,000 shares
@ $15, valued at
$3.5M
Converted 13,950,000 preferred shares
@ $0 Converted 6,500,000 preferred shares
@ $0 Converted 3,000,000 preferred shares
@ $0 Converted 2,333,333 preferred shares
@ $0 Converted 1,320,097 preferred shares
@ $0 |
|
09/22/2020 |
4
| ARCH Venture Fund VIII, L.P. (10% Owner) has filed a Form 4 on Metacrine, Inc.
Txns:
| Converted 1,960,784 shares
@ $0 Converted 472,251 shares
@ $0 Converted 138,734 shares
@ $0 Bought 210,000 shares
@ $13, valued at
$2.7M
Converted 138,734 shares
@ $0 Bought 20,000 shares
@ $13, valued at
$260k
Converted 1,960,784 convertible preferred
@ $0 Converted 472,251 convertible preferred
@ $0 Converted 138,734 convertible preferred
@ $0 Converted 138,734 convertible preferred
@ $0 |
|
06/12/2020 |
4
| BYBEE CLINTON (Director) has filed a Form 4 on IMPINJ INC
Txns:
| Granted 2,849 restricted stock units
@ $0 |
|
02/11/2020 |
4
| ARCH Venture Partners IX, LLC (10% Owner) has filed a Form 4 on Beam Therapeutics Inc.
Txns:
| Converted 4,121,520 shares
@ $0 Converted 4,121,519 shares
@ $0 Converted 1,338,000 preferred shares
@ $0 Converted 1,338,000 preferred shares
@ $0 Converted 2,750,336 preferred shares
@ $0 Converted 2,750,335 preferred shares
@ $0 Converted 33,184 preferred shares
@ $0 Converted 33,184 preferred shares
@ $0 |
|
11/19/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/24/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/18/2019 |
4
| ARCH Venture Partners IX, LLC (10% Owner) has filed a Form 4 on Vir Biotechnology, Inc.
Txns:
| Converted 11,666,665 shares
@ $0 Converted 15,555,554 shares
@ $0 Bought 1,000,000 shares
@ $20, valued at
$20M
Converted 11,111,110 convertible preferred
@ $0 Converted 13,333,332 convertible preferred
@ $0 Converted 555,555 convertible preferred
@ $0 Converted 2,222,222 convertible preferred
@ $0 |
|
|
|
|